"A randomized, double-blind Phase III study of copanlisib versus placebo in patients with rituximab-refractory indolent non-Hodgkin’s lymphoma (iNHL) – CHRONOS-2"
2022-06-28
عنوان الدراسة
"A randomized, double-blind Phase III study of copanlisib versus placebo in patients with rituximab-refractory indolent non-Hodgkin’s lymphoma (iNHL) – CHRONOS-2"
داعم الدراسة
Bayer
دواء الدراسة
BAY 80-6946/Copanlisib
رقم بروتوكول الدراسة
BAY 80-6946 / 17322
حالة الدراسة
Terminated
موقع الدراسة
KAUH-J
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.